Volume Alert - HAL 54.77 Halliburton Company $HAL Hit a

New Post Public Reply Private Reply Replies (0) Message Board
leahanne
Volume Alert - HAL 54.77 Halliburton Company $HAL Hit a high today of 56.26 Closing the day 10:30 at 54.77 +0.98 +1.82% With a day low of 54.60 and a total volume of 8,596,394.

HAL Recent Posts: http://investorshangout.com/Halliburton-Company-HAL-51242/

HAL Halliburton Company Recent Headline News

Stocks Mixed In Mild Trade; Movado Collapses On Outlook
at Investor's Business Daily - 10 mins ago
Stocks pecked out a narrowly mixed open Friday, as many energy issues rebounded and economic news was generally positive. The Nasdaq dipped 0.1%. The Dow Jones industrial average and the S&P 500 each rose a fraction. Trade ebbed 1% on the Nasdaq and...
SINA: 39.48 (-2.37), YY: 75.81 (+4.14), HAL: 53.99 (+0.20), MOD: 12.41 (+0.01), BITA: 88.24 (+8.95), SLB: 95.04 (+0.19), BHI: 58.55 (-0.20)

Stock Market Today: Stocks Turn Higher as Retail Sales Rise, Sentiment Spikes
at The Street - 45 mins ago
U.S. stocks are higher after better-than-expected domestic retail sales prove a good omen for the fast-approaching holiday shopping season.
VA: 29.30 (+29.30), HAL: 53.99 (+0.20), JWN: 74.98 (+1.73), LULU: 44.75 (-0.44), BHI: 58.55 (-0.20)

Stock Market News for November 14, 2014 - Market News
Zacks Equity Research - Zacks Investment Research - 51 mins ago
Benchmarks finished almost unchanged on Thursday as investors weighed upbeat corporate earnings results and deal news against another fall in energy shares
HAS: 55.00 (+0.02), HAL: 53.98 (+0.19), XOM: 95.03 (+0.37), COP: 71.05 (+0.70), WMT: 82.73 (-0.21), DWA: 26.29 (+0.77), SLB: 95.04 (+0.19), EOG: 97.31 (+1.46), TWC: 140.82 (-0.23), PG: 88.62 (+0.02), MSFT: 49.83 (+0.22), CVX: 116.07 (-0.38), CSCO: 25.99 (+0.31), BHI: 58.55 (-0.20)

3 Reasons Halliburton Company Stock Could Rise
Nickey Friedman, The Motley Fool - Motley Fool - 1 hr 19 mins ago
After hitting an all-time high of $74.33 back in July, shares of Halliburton Company have dropped like a shale stone to as low as $47.60 alongside collapsing oil prices. Is the oil boom over for companies like Halliburton, or is the recent dip an...
HAL: 53.99 (+0.20)


US stocks are little changed in early trading
AP - 1 hr 20 mins ago
NEW YORK (AP) — U.S. stock indexes are little changed in early trading, while energy companies recover.
HAL: 53.99 (+0.20)

Stocks Futures Narrow Losses; Deal Chatter Lifts Baker Hughes
at Investor's Business Daily - 1 hr 45 mins ago
Stock futures upshifted from early losses, pointing to a mixed open Friday after better-than-expected retail sales numbers. Dow futures shed early losses and climbed 9.2 points above fair market value. S&P 500 futures also reversed and rose a...
SINA: 39.48 (-2.37), WB: 19.46 (-0.16), YY: 75.81 (+4.14), TUBE: 18.88 (+0.87), HAL: 53.99 (+0.20), BITA: 88.15 (+8.86), SLB: 95.04 (+0.19), BHI: 58.55 (-0.20)

The Department Of Energy Graph That Presaged The Plunge In Oil Prices And What That Graph Is Now Projecting
Dante Caruso - at Seeking Alpha - 2 hrs 6 mins ago

USO: 28.53 (+0.24), OIH: 43.70 (-0.07), HAL: 53.99 (+0.20), SLB: 95.04 (+0.19), BHI: 58.55 (-0.20)

Goldman Sachs Advising Baker Hughes, Credit Suisse With Halliburton on Talks
at The Street - 2 hrs 8 mins ago
Goldman is advising Baker Hughes while Credit Suisse is assisting Halliburton on a possible merger.
GS: 190.01 (-0.23), HAL: 53.99 (+0.20), BHI: 58.55 (-0.20)

Stock Market Today: Stock Futures Rise as U.S. Retail Sales Jump
at The Street - 2 hrs 22 mins ago
U.S. futures are higher on Friday following better-than-expected retail sales.
HAL: 53.99 (+0.20), JWN: 74.98 (+1.73), BHI: 58.55 (-0.20)

Wall Street Breakfast: France, Germany Report Slight Growth In Q3
Wall Street Breakfast - Seeking Alpha - Fri Nov 14, 5:31AM CST
Economy France’s economy grew for the first time this year during the third quarter and Germany narrowly avoided sliding back into recession, as the two reported Q3 GDP data today. French GDP expanded by 0.3% Q/Q, above forecasts of 0.2%,...
AMZN: 324.85 (+8.37), HAL: 54.00 (+0.21), RBS: 11.75 (unch), ASCMA: 53.55 (+1.57), ORCL: 40.82 (+0.10), SBUX: 78.08 (+0.19), PBR: 9.65 (-0.55), SAP: 66.60 (-0.03), SPY: 204.15 (-0.04), VA: 29.30 (+29.30), QQQ: 102.88 (-0.02), BP: 40.79 (+0.12), PG: 88.62 (+0.02), BRK.B: 146.29 (unch), HMC: 31.98 (+0.45), BRK.A: 219,438.00 (+138.00), PLNR: 6.87 (+0.20), BHI: 58.55 (-0.20)

'Fast Money' Recap: Oil Hasn't Bottomed but These Stocks Have
at The Street - Fri Nov 14, 4:00AM CST
The trading panel took a look at oil services stocks, which appear to have bottomed, while crude oil continues its descent.
HAS: 55.00 (+0.02), HAL: 54.00 (+0.21), WMT: 82.73 (-0.21), M: 62.18 (+0.61), TIF: 102.83 (-0.48), DWA: 26.29 (+0.77), SPWR: 27.14 (-0.94), SLB: 95.05 (+0.20), LGF: 35.21 (-0.01), QCOM: 70.76 (+0.11), TGT: 67.73 (+0.23), TWTR: 40.42 (+0.38), MSFT: 49.83 (+0.22), JJC: 36.69 (+0.63), BHI: 58.55 (-0.20)

The One Sector You Must Own Today (Part I)
Joseph L. Shaefer - Seeking Alpha - Fri Nov 14, 1:31AM CST
As recently as 24 hours ago, I would have included Baker Hughes (NYSE: BHI ) in my discussion below. But near the close yesterday, Halliburton divulged that it would like to acquire its very large rival Baker Hughes. BHI jumped 15% in 25 minutes....
KMI: 38.80 (+0.42), NOV: 70.58 (-0.94), EVEP: 29.95 (+0.48), OKE: 56.11 (+0.46), HAL: 53.99 (+0.20), NKA: 4.65 (-0.08), PAA: 52.83 (+0.53), STO: 22.01 (+0.44), BHI: 58.55 (-0.20)

Potential Halliburton And Baker Hughes Deal Indicates Oil Stocks Are Probably Too Cheap
Hawkinvest - at Seeking Alpha - Fri Nov 14, 1:03AM CST

HAL: 53.99 (+0.20), BHI: 58.55 (-0.20)

While Halliburton Is Busy Digesting Baker Hughs, Schlumberger Can Take The Lead
Zachary Mannes - at Seeking Alpha - Fri Nov 14, 12:55AM CST

USO: 28.53 (+0.24), HAL: 53.99 (+0.20), SLB: 95.05 (+0.20), XLE: 85.69 (+0.35), BHI: 58.55 (-0.20)

Oil Equipment Stock Showdown: Schlumberger (SLB) vs. Halliburton (HAL) - Stocks in the News
Zacks Research Staff - Zacks Investment Research - Thu Nov 13, 8:36PM CST
Taking a closer look at two of the biggest oil equipment stocks in the market.
HAL: 53.99 (+0.20), SLB: 95.03 (+0.18)

Baker Hughes says in deal talks with Halliburton
The Associated Press - AP - Thu Nov 13, 7:52PM CST
HOUSTON (AP) — Oilfield-services provider Baker Hughes Inc. said Thursday it is talks with rival Halliburton Co. about a potential merger.
HAL: 53.99 (+0.20), BHI: 58.55 (-0.20)

Judge sticks to BP gross negligence ruling
By KEVIN McGILL - AP - Thu Nov 13, 7:10PM CST
NEW ORLEANS (AP) — A federal judge in New Orleans is sticking to his ruling that said BP's conduct in the 2010 Gulf of Mexico oil rig disaster amounted to "gross negligence."
RIG: 26.04 (-0.25), HAL: 53.99 (+0.20), BP: 40.79 (+0.12)

Fracking accident kills 1, injures 2 in Colorado
AP - Thu Nov 13, 6:13PM CST
GREELEY, Colo. (AP) — An accident at a hydraulic fracturing site in northern Colorado killed one worker and seriously injured two others Thursday, authorities said.
HAL: 53.99 (+0.20), APC: 89.63 (+0.17)

Halliburton-Baker Hughes combo risks customer backlash
Seeking Alpha - at Seeking Alpha - Thu Nov 13, 5:56PM CST

HAL: 53.99 (+0.20), SLB: 95.04 (+0.19), BHI: 58.55 (-0.20)

Most active New York Stock Exchange-traded stocks
AP - Thu Nov 13, 5:05PM CST
NEW YORK (AP) — A look at New York Stock Exchange 10 most-active stocks at the close of trading:
KMI: 38.80 (+0.42), ZTS: 43.11 (-0.13), GE: 26.47 (+0.05), F: 15.25 (+0.32), S: 5.02 (+0.02), PFE: 30.28 (-0.14), JCP: 7.25 (+0.15), HAL: 53.99 (+0.20), WMT: 82.73 (-0.21), BAC: 17.20 (-0.02), TWTR: 40.44 (+0.40), GNW: 9.38 (+0.08)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 119

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
Stavian Group Eyes AI-Driven Southeast Asia Growth

Updated Category News Views 50

AI and Infrastructure: A New Chapter for Southeast Asia What does Southeast Asia's future look like with AI steering the ship? Well, there's a fresh breeze of change blowing, and right at the heart of it stands Stavian Group. At the recently held inaugural Fortune SEA500 Summit in Ho Chi Minh City, this conglomerate threw its hat into the ring, painting a vision of growth...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 612

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Updated Category News Views 56

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 351

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
CureGene's Evategrel Aims for Breakthrough in Stroke Care

Updated Category News Views 69

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 344

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 245

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 273

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 84

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading

Top 5 Most Recently Viewed Articles

Equitage Ventures Launches $47.3M Fund for Senior Care Tech

Updated Category News Views 329

Equitage Ventures Launches Significant Investment Fund Equitage Ventures, an early-stage venture capital firm dedicated to AgeTech, has announced the successful final closing of a substantial $47.3 million investment fund. This fund is designed to provide critical capital, distribution resources, and strategic guidance to innovative entrepreneurs who aim to tackle the...

Continue Reading
Understanding Market Trends: Insights into Chevron Corp's Performance

Updated Category News Views 171

Chevron Corp Market Sentiment Analysis Chevron Corp (NYSE: CVX) has experienced a noteworthy decline in its short interest as a percentage of float, showing a 10.26% decrease since its previous report. Currently, there are approximately 14.02 million shares sold short, which accounts for 0.7% of all shares available for trading. Given the trading volume, it is estimated...

Continue Reading
Establishment of Blakely McCrory Hope Fund at Moody Gardens

Updated Category News Views 200

Introducing the Blakely McCrory Hope Fund Moody Gardens is proud to announce a special initiative to honor the memory of a young girl who captured the hearts of many: the Blakely McCrory Hope Fund. This fund has been established in loving memory of 8-year-old Blakely McCrory, who lost her life in a tragic flooding incident that occurred during the summer months....

Continue Reading
Star-Studded Table Read of 'It's a Wonderful Life' Event

Updated Category News Views 221

Exciting Holiday Table Read for a Worthy Cause The Ed Asner Family Center is pulling out all the stops this holiday season with an exciting virtual table read of the beloved classic, "It's a Wonderful Life." Scheduled for December 14 at 5 PM PST, this event promises to spread joy while supporting individuals and families with special needs. Star-Studded Cast Comes...

Continue Reading
Transforming $100 Into Over $1700 with Monolithic Power Systems

Updated Category News Views 145

Understanding the Growth of Monolithic Power Systems Monolithic Power Systems (NASDAQ: MPWR) has showcased impressive financial performance over the past decade, outperforming many market benchmarks. With an impressive annualized growth rate of 19.88%, it has attracted the attention of savvy investors. The Power of Compounded Returns Imagine investing $100 in MPWR stock...

Continue Reading